IDiyas

For the Inventor, By the Inventor

Shiga, Japan

Fusao Ueda

USPTO Granted Patents = 11

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Kyoto, JA (1976)
  • Shige, JP (1987)
  • Shiga, JP (1978 - 1999)

Company Filing History:

goldMedal11 out of 229 
 
Nippon Shinyaku Company, Ltd.
 patents

Years Active: 1976-1999

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5962454 - Neovascularization inhibitor (1999-10-05),
2. 5962453 - Triazine derivative and medicine (1999-10-05),
3. 5885993 - Remedy for pancreatitis (1999-03-23),
4. 4874762 - 2-amino-4-nicotinoylamino-6-aryl-s-triazines as nootropic agents (1989-10-17),
5. 4873242 - 2,4-diamino-6-substituted-phenyl-S-triazines as nootropic agents (1989-10-10),
6. 4657907 - Low dosage compositions of finely pulverized (1987-04-14),
7. 4532238 - Finely pulverized 2,4-diamino-6-(2,5-dichloro-phenyl)-1,3,5-triazine and (1985-07-30),
8. 4487770 - Treatment of diseases of the liver, kidney, colon and rectum (1984-12-11),
9. 4103009 - Benzoguanamine derivatives (1978-07-25),
10. 4098892 - Nicotinamido-s-triazines (1978-07-04),
11. 3966728 - Benzoguanamine derivatives (1976-06-29),

Title: The Innovative Contributions of Fusao Ueda

Introduction

Fusao Ueda is a prominent inventor based in Shiga, Japan, known for his significant contributions to the field of medicine through his innovative patents. With a total of 11 patents to his name, Ueda's work has been pivotal in advancing medical therapies and treatments.

Latest Patents

Among his recent innovations, Ueda developed a neovascularization inhibitor, specifically a triazine derivative, which has shown promise in various medical applications. His work in this area demonstrates his commitment to addressing complex health challenges through groundbreaking inventions.

Career Highlights

Ueda is currently affiliated with Nippon Shinyaku Company, Ltd., where he continues to push the boundaries of pharmaceutical research and development. His expertise in medicine and dedication to innovation have made him an essential asset to the company and the broader scientific community.

Collaborations

Throughout his career, Ueda has collaborated with esteemed colleagues such as Yoshiaki Aoyagi and Hiromu Murai. These partnerships have not only enhanced his research endeavors but also facilitated the development of innovative medical solutions within their collective fields of expertise.

Conclusion

Fusao Ueda's contributions as an inventor are noteworthy, as evidenced by his extensive patent portfolio and collaborative efforts with other professionals in the industry. His ongoing work at Nippon Shinyaku Company, Ltd. is expected to further strengthen the advances in medical treatment through innovation and inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…